uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
Show others and affiliations
2009 (English)In: Annals of Clinical Biochemistry, ISSN 0004-5632, Vol. 46, no Part 3, 235-240 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Different cerebrospinal fluid (CSF) amyloid-beta 1-42 (Abeta(1-42)), total Tau (Tau) and Tau phosphorylated at threonine 181 (P-Tau) levels are reported, but currently there is a lack of quality control programmes. The aim of this study was to compare the measurements of these CSF biomarkers, between and within centres. METHODS: Three CSF-pool samples were distributed to 13 laboratories in 2004 and the same samples were again distributed to 18 laboratories in 2008. In 2004 six laboratories measured Abeta(1-42), Tau and P-Tau and seven laboratories measured one or two of these marker(s) by enzyme-linked immunosorbent assays (ELISAs). In 2008, 12 laboratories measured all three markers, three laboratories measured one or two marker(s) by ELISAs and three laboratories measured the markers by Luminex. RESULTS: In 2004, the ELISA intercentre coefficients of variance (interCV) were 31%, 21% and 13% for Abeta(1-42), Tau and P-Tau, respectively. These were 37%, 16% and 15%, respectively, in 2008. When we restricted the analysis to the Innotest((R)) (N = 13) for Abeta(1-42), lower interCV were calculated (22%). The centres that participated in both years (N = 9) showed interCVs of 21%, 15% and 9% and intra-centre coefficients (intraCV) of variance of 25%,18% and 7% in 2008. CONCLUSIONS: The highest variability was found for Abeta(1-42). The variabilities for Tau and P-Tau were lower in both years. The centres that participated in both years showed a high intraCV comparable to their interCV, indicating that there is not only a high variation between but also within centres. Besides a uniform standardization of (pre)analytical procedures, the same assay should be used to decrease the inter/intracentre variation.

Place, publisher, year, edition, pages
2009. Vol. 46, no Part 3, 235-240 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-102711DOI: 10.1258/acb.2009.008232ISI: 000266289800009PubMedID: 19342441OAI: oai:DiVA.org:uu-102711DiVA: diva2:216632
Available from: 2009-05-11 Created: 2009-05-11 Last updated: 2010-07-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lannfelt, Lars
By organisation
In the same journal
Annals of Clinical Biochemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 205 hits
ReferencesLink to record
Permanent link

Direct link